PEDIACARE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PEDIACARE
Largest movements
- Cash +€57,666
up €57,666 (+18.8%), from €306,197 to €363,863
mainly Net result for the year (+€71,446) and Trade debts (+€3,950)
- Receivables within one year +€7,597
up €7,597 (+59.1%), from €12,861 to €20,458
of which Other amounts receivable: +€7,960
- Reserves +€71,446
up €71,446 (+24.6%), from €290,708 to €362,155
- Short-term financial debts -€10,372
no longer reported in 2025 (was €10,372)
- Trade debts +€3,950
up €3,950 (+303.2%), from €1,303 to €5,252
- Depreciation -€5,139
down €5,139 (-90.8%), from €5,659 to €520
- Gross operating margin -€3,851
down €3,851 (-3.7%), from €102,914 to €99,063
- Financial charges -€1,573
down €1,573 (-86.5%), from €1,818 to €245
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €321,133 | €386,112 | +€64,979 | +20.2% |
| Fixed assets | 21/28 | €1,161 | €1,790 | +€629 | +54.2% |
| Tangible fixed assets | 22/27 | €1,161 | €1,790 | +€629 | +54.2% |
| Furniture and vehicles | 24 | €1,161 | €1,790 | +€629 | +54.2% |
| Current assets | 29/58 | €319,972 | €384,322 | +€64,350 | +20.1% |
| Amounts receivable within one year | 40/41 | €12,861 | €20,458 | +€7,597 | +59.1% |
| Trade receivables | 40 | €363 | - | -€363 | |
| Other amounts receivable | 41 | €12,498 | €20,458 | +€7,960 | +63.7% |
| Cash at bank and in hand | 54/58 | €306,197 | €363,863 | +€57,666 | +18.8% |
| Deferred charges and accrued income | 490/1 | €914 | - | -€914 | |
| Total equity and liabilities | 10/49 | €321,133 | €386,112 | +€64,979 | +20.2% |
| Equity | 10/15 | €309,308 | €380,755 | +€71,446 | +23.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €290,708 | €362,155 | +€71,446 | +24.6% |
| Distributable reserves | 133 | €290,708 | €362,155 | +€71,446 | +24.6% |
| Amounts payable | 17/49 | €11,825 | €5,357 | -€6,468 | -54.7% |
| Amounts payable within one year | 42/48 | €11,675 | €5,252 | -€6,423 | -55.0% |
| Financial debts | 43 | €10,372 | - | -€10,372 | |
| Credit institutions | 430/8 | €10,372 | - | -€10,372 | |
| Trade debts | 44 | €1,303 | €5,252 | +€3,950 | +303.2% |
| Suppliers | 440/4 | €1,303 | €5,252 | +€3,950 | +303.2% |
| Accrued charges and deferred income | 492/3 | €150 | €105 | -€45 | -30.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,659 | €520 | -€5,139 | -90.8% |
| Other operating charges | 640/8 | €673 | €695 | +€22 | +3.3% |
| Gross operating margin | 9900 | €102,914 | €99,063 | -€3,851 | -3.7% |
| Operating profit (loss) | 9901 | €96,583 | €97,848 | +€1,265 | +1.3% |
| Financial income | 75/76B | €1,083 | €939 | -€144 | -13.3% |
| Recurring financial income | 75 | €1,083 | €939 | -€144 | -13.3% |
| Financial charges | 65/66B | €1,818 | €245 | -€1,573 | -86.5% |
| Recurring financial charges | 65 | €1,818 | €245 | -€1,573 | -86.5% |
| Profit (loss) for the period before taxes | 9903 | €95,848 | €98,542 | +€2,694 | +2.8% |
| Income taxes | 67/77 | €26,360 | €27,095 | +€735 | +2.8% |
| Profit (loss) for the period | 9904 | €69,488 | €71,446 | +€1,959 | +2.8% |
| Profit (loss) for the period to be appropriated | 9905 | €69,488 | €71,446 | +€1,959 | +2.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.